Company Quick10K Filing
GeoVax Labs
10-Q 2020-09-30 Filed 2020-11-05
S-1 2020-07-20 Public Filing
10-Q 2020-06-30 Filed 2020-08-10
10-Q 2020-03-31 Filed 2020-05-05
10-K 2019-12-31 Filed 2020-03-24
10-Q 2019-09-30 Filed 2019-11-07
10-Q 2019-06-30 Filed 2019-08-13
10-Q 2019-03-31 Filed 2019-05-13
10-K 2018-12-31 Filed 2019-03-26
10-Q 2018-09-30 Filed 2018-11-08
10-Q 2018-06-30 Filed 2018-08-07
10-Q 2018-03-31 Filed 2018-05-03
10-K 2017-12-31 Filed 2018-03-23
10-Q 2017-09-30 Filed 2017-11-09
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-12
10-K 2016-12-31 Filed 2017-03-24
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-05
10-Q 2016-03-31 Filed 2016-05-04
10-K 2015-12-31 Filed 2016-03-16
10-Q 2015-09-30 Filed 2015-11-12
10-Q 2015-06-30 Filed 2015-08-04
10-Q 2015-03-31 Filed 2015-05-14
10-K 2014-12-31 Filed 2015-03-20
10-Q 2014-09-30 Filed 2014-11-12
10-Q 2014-06-30 Filed 2014-08-08
10-Q 2014-03-31 Filed 2014-05-02
10-K 2013-12-31 Filed 2014-03-14
10-Q 2013-09-30 Filed 2013-11-12
10-Q 2013-06-30 Filed 2013-08-12
10-Q 2013-03-31 Filed 2013-05-01
10-K 2012-12-31 Filed 2013-03-18
10-Q 2012-09-30 Filed 2012-11-13
10-Q 2012-06-30 Filed 2012-08-13
10-Q 2012-03-31 Filed 2012-05-14
10-Q 2011-09-30 Filed 2011-11-10
10-Q 2011-06-30 Filed 2011-08-12
10-Q 2011-03-31 Filed 2011-04-27
10-K 2010-12-31 Filed 2011-03-04
10-Q 2010-09-30 Filed 2010-11-08
10-Q 2010-06-30 Filed 2010-08-06
10-Q 2010-03-31 Filed 2010-05-04
10-K 2009-12-31 Filed 2010-03-08
8-K 2021-02-11
8-K 2021-02-08
8-K 2020-11-25
8-K 2020-11-05
8-K 2020-10-22
8-K 2020-09-29
8-K 2020-09-24
8-K 2020-08-25
8-K 2020-08-10
8-K 2020-08-07
8-K 2020-06-26
8-K 2020-06-19
8-K 2020-05-18
8-K 2020-05-06
8-K 2020-04-17
8-K 2020-03-25
8-K 2020-03-06
8-K 2020-01-23
8-K 2020-01-21
8-K 2020-01-03
8-K 2019-11-14
8-K 2019-11-07
8-K 2019-10-24
8-K 2019-10-16
8-K 2019-10-01
8-K 2019-09-30
8-K 2019-08-14
8-K 2019-08-02
8-K 2019-07-24
8-K 2019-07-16
8-K 2019-06-19
8-K 2019-05-14
8-K 2019-04-30
8-K 2019-04-26
8-K 2019-04-15
8-K 2019-03-27
8-K 2019-02-25
8-K 2019-02-18
8-K 2019-01-22
8-K 2018-12-27
8-K 2018-11-08
8-K 2018-08-31
8-K 2018-08-13
8-K 2018-08-07
8-K 2018-06-14
8-K 2018-05-03
8-K 2018-03-23
8-K 2018-03-05

GeoVax Labs Financials

GOVX Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-06-302011-09-302011-12-312011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash6685671,1681,1682,2401,8171,5841,0361,7511,8811,7212,5142,0101,3728621,1023,1472,4761,8211,060669215511454167823344313571191511260176216569
Accounts Receivable
Inventory
PP&E2071861761761581391215328772144619619630654654670670670670670670670670675675675675675675675675679679679
Assets2,1341,8131,6451,6452,8372,2902,0361,4782,1302,0441,9612,8402,1731,5211,0531,3333,3592,6641,9981,332796339675610304990496490840371623642473343817
Accounts Payable138138184296916411139851561351158256461114210110339337615115211878546614812625311663
Long-Term Debt49464340353229
Liabilities7316509429425103803383273501522263122352371701872171811181271661802533705486527328119681,1141,3481,6641,6801,6711,837
Stockholders' Equity1,4041,1627047042,3271,9101,6981,1511,7801,8931,7362,5271,9381,2838831,1463,1422,4831,8801,205630159423240-244338-236-321-129-743-724-1,022-1,207-1,329-1,021
Income Statement ($'000)2011-06-302011-09-302011-12-312011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue22193349364210333
Cost of Revenue
Gross Profit
R&D1,3851,0909639631,072712602657882553879601403516425468385379526438398684451552518498449487372558556451468
SG&A5795831,1481,148513492334413613416316447372345412679365336327907345221659293352340247357359459510413291
Tax00000000000
Net Income-211-376-1,153-1,153-731-498-297-610-697-526-190-872-616-680-515-924-700-676-620-693-1,296-576-464-935-548-517-589-516-622-637-667-701-654-424
Cash Flow ($'000)2011-06-302011-09-302011-12-312011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-527575-1,237-423-233-548-344-453-74-823-504-627-485-634-619-671-655-761-629-545-332-429-448-382-380-280-317-456-344
Cash Investing0-12-12000000-870-240-1600000-400000-400
Cash Financing-495395392,3090001,0605831,61602,68000023891491,0854176400600238497697